Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma
Conditions
- Locally Advanced Melanoma
Interventions
- DRUG: Fianlimab + Cemiplimab
- DRUG: Relatlimab + Nivolumab
Sponsor
John Kirkwood
Collaborators